PHE Renewed for Another 90 Days Pushing it to April 2023

Published in Government Relations on January 11, 2023

On Wednesday, Jan. 11, 2023, HHS Secretary Xavier Becerra announced an extension of the COVID-19 Public Health Emergency (PHE). This extension will last another 90 days from January 11. PHE declarations, and subsequent extensions such as this one, only last for 90 days at a time but can be further renewed as many times as necessary. The COVID-19 PHE has been renewed multiple times since early 2020. 

What PHE Extenstion Means For DMEPOS Suppliers 

There are several provisions which impact our industry that are tied to the duration of the PHE that will remain in place due to the extension of the PHE, including:  

  • Medicare’s 75/25 blended rates for non-rural, non-CBA areas (these increased reimbursement rates will no longer end immediately when the PHE is ultimately declared over) 
  • COVID-19 testing at no cost to the patient  
  • Waivers of certain telehealth restrictions  
  • Waivers related to Medicare medical policies (LCD)  

A full list of those waivers can be found here

Remember, the competitive bid areas (CBAs) continue with the existing payment methodology, known as the single payment amount (SPA); the PHE extension does not affect payments in these areas.  

Reimbursement rates are determined based on the beneficiary's permanent address on file with SSA.  

The next reconsideration for the PHE renewal will occur in April 2023. 

While the PHE has been renewed for another 90 days, it would be a suitable time for suppliers to begin preparations for the PHE to be terminated. This means running reports to look for claims that are still being submitted with the CR modifier and “COVID-19” in the claimed narrative. Also, be familiar with the patients living in the non-rural, non-CBA areas because these areas will be affected by the reimbursement rates changing (that decrease in reimbursement will likely happen at the end of 2023). We do know that HHS Secretary Becerra has stated that a 60-day notice will be announced prior to the termination of the PHE. We also know CMS will provide instructions near that 60-day notice of termination that will guide suppliers regarding the policies and waivers outlined above after the PHE has expired. 


TAGS

  1. hhs
  2. phe
  3. vgm
  4. vgm government

From Our Experts

CRT Bill H.R. 1703 Advances Through Full Energy & Commerce Committee thumbnail CRT Bill H.R. 1703 Advances Through Full Energy & Commerce Committee Earlier this week, we shared that H.R. 1703 advanced through the House Energy & Commerce Health Subcommittee. We are pleased to report that the bill has continued to gain momentum and has now successfully passed out of the full Energy & Commerce Committee unanimously following today's markup. Important Update: Prior Auth Exemption Process – Deadline Extended to May 26, 2026 thumbnail Important Update: Prior Auth Exemption Process – Deadline Extended to May 26, 2026 CMS has just announced that the deadline to opt out of the prior authorization exemption and continue submitting prior authorization requests has been extended to Tuesday, May 26. This extension only applies to suppliers that received a letter from the DME MACs in early March regarding their prior authorization exemption status. CRT Bill H.R. 1703 Advances Through Energy and Commerce Health Subcommittee thumbnail CRT Bill H.R. 1703 Advances Through Energy and Commerce Health Subcommittee As announced during the NCART and AAHomecare Legislative Conference last week, H.R. 1703, the Choices for Increased Mobility Act, was considered and advanced out of the House Energy & Commerce Health Subcommittee. This is a positive step forward for the CRT community. VGM Government Relations Team Advocates for DME in Washington, D.C. thumbnail VGM Government Relations Team Advocates for DME in Washington, D.C. VGM Government Relations team members joined industry leaders in Washington, D.C., this week for a series of impactful advocacy events, including the 2026 AAHomecare Legislative Conference, NCART Legislative Conference, and the AAHomecare Payer Relations Council meeting. BREAKING NEWS: Big Win For DME Industry in North Carolina thumbnail BREAKING NEWS: Big Win For DME Industry in North Carolina Congratulations to ACMESA on the passage of a Medicaid funding bill, which provides important stability for DMEPOS providers and the patients they serve. Invite Your Federal Legislator to the CRT Product Expo in Washington, D.C. thumbnail Invite Your Federal Legislator to the CRT Product Expo in Washington, D.C. During the upcoming NCART/iNRRTS U.S. Rehab Legislative Conference, NCART and U.S. Rehab will host a Complex Rehab Technology (CRT) Product Expo on May 13 from 11:30 a.m. to 2:00 p.m. in Washington, D.C. This Expo is a valuable opportunity for members of Congress and their staff to see firsthand how CRT products impact independence, mobility, and quality of life for individuals with disabilities. Network Bidding Opens New Path for Small DMEPOS Suppliers thumbnail Network Bidding Opens New Path for Small DMEPOS Suppliers CMS released a new FAQ clarifying that small DMEPOS suppliers may form networks to collectively meet licensure, accreditation, and enrollment requirements for the next round of the Competitive Bidding Program. This guidance creates a new pathway for small suppliers to compete, with additional education and networking support available through VGM initiatives. VGM Group Highlights Value of DMEPOS Industry and Commends Efforts to Protect Patients and Communities thumbnail VGM Group Highlights Value of DMEPOS Industry and Commends Efforts to Protect Patients and Communities VGM Group continues to underscore the effectiveness and efficiency of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) industry and its critical role across the healthcare continuum. The services and support provided by DMEPOS suppliers not only enhance patient outcomes and strengthen community health, but do so in a cost-effective manner that delivers meaningful savings to the healthcare system.